Skip to main content

Table 3 Number and frequency of different types of COVID-19 preventive measures used and COVID-19 symptoms distinguished by HIV status

From: SARS-CoV-2 seroprevalence and associated factors, based on HIV serostatus, in young people in Sofala province, Mozambique

 

HIV- (n = 450)

HIV + (n = 90)

p–Value*

Overall (n = 540)

COVID-19 preventive measures

 Wearing a mask

430 (95.6%)

86 (95.6%)

0.998

516 (95.6%)

 Keeping distance

191 (42.4%)

36 (40.0%)

0.726

227 (42.0%)

 Avoiding crowded areas

167 (37.1%)

28 (31.1%)

0.336

195 (36.1%)

 Hand wash

374 (83.1%)

77 (85.6%)

0.643

451 (83.5%)

 

HIV- (n = 220)

HIV + (n = 33)

 

Overall (n = 253)

COVID-19 Symptomsa (N/A = 12)

 Total with symptoms

61 (29.2%)

7 (21.9%)

0.527

68 (28.2%)

 Fever

47 (22.5%)

6 (18.8%)

0.820

53 (22.0%)

 Cough

49 (23.4%)

6 (18.8%)

0.821

55 (22.8%)

 Sore throat

38 (18.2%)

3 (9.4%)

0.315

41 (17.0%)

 Anosmia

14 (6.7%)

1 (3.1%)

0.701

15 (6.2%)

 Breathing difficulty

3 (1.4%)

2 (6.3%)

0.128

5 (2.1%)

 Hospitalization

0 (0.0%)

0 (0.0%)

0.998

0 (0.0%)

  1. *Fisher’s exact and χ2 test
  2. aAmong people with a positive result for SARS-CoV-2 antibodies